Oryzon Genomics SA (ORYZF)
3.31
0.00 (0.00%)
USD |
OTCM |
Sep 24, 16:00
Oryzon Genomics Gross Profit (Annual) : -0.1511M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.1511M |
| December 31, 2024 | -0.1598M |
| December 31, 2023 | -0.1653M |
| December 31, 2022 | -0.1752M |
| December 31, 2021 | -0.1706M |
| December 31, 2020 | -0.1654M |
| December 31, 2019 | -0.1675M |
| Date | Value |
|---|---|
| December 31, 2018 | -0.1728M |
| December 31, 2017 | -3.639M |
| December 31, 2016 | -2.400M |
| December 31, 2015 | 3.312M |
| December 31, 2014 | 13.09M |
| December 31, 2013 | -3.135M |
| December 31, 2012 | -0.821M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Pharma Mar SA | 226.97M |
| Grifols SA | 3.031B |
| ACADIA Pharmaceuticals, Inc. | 971.62M |
| Alkermes Plc | 1.274B |
| Alnylam Pharmaceuticals, Inc. | 3.032B |